BioticsAI announced it has received FDA clearance for its AI software designed to help detect fetal abnormalities in ultrasound images. Founder and CEO Robhy Bustami said the computer-vision system supports fetal ultrasound quality assessment, checks anatomical completeness, automates reporting, and integrates into clinical workflows. Bustami, who grew up around obstetric care in a family of obstetricians and studied computer science at UC Irvine, co-founded the company in 2021 with Salman Khan, Chaskin Saroff, and Dr. Hisham Elgammal. He said the technology aims to help address poor prenatal outcomes in the U.S., including disproportionately high maternal death rates among Black women, and noted that prenatal ultrasound is central to pregnancy monitoring.